We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.6B
AUM Growth
+$1.7B
(+3.6%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
16.96%
Holding
3,019
New
199
Increased
1,870
Reduced
823
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
Microsoft
MSFT
|
+$29.1M |
| 3 |
Evergy
EVRG
|
+$26.2M |
| 4 |
Amazon
AMZN
|
+$25.8M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$130M |
| 2 |
MON
Monsanto Co
MON
|
+$88.9M |
| 3 |
Apple
AAPL
|
+$21.2M |
| 4 |
Keurig Dr Pepper
KDP
|
+$18.4M |
| 5 |
Gilead Sciences
GILD
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.45% |
| 2 | Financials | 16.24% |
| 3 | Healthcare | 13.05% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1626
DELISTED
Faro Technologies
FARO
| $2.2M | ﹤0.01% |
40,549
+518
| +1% | +$28.9K |
|
1627
Moelis & Co
MC
$4.97B
| $2.2M | ﹤0.01% |
37,470
+9,192
| +33% | +$528K |
|
|
GBT
1628
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.2M | ﹤0.01% |
48,618
+12,622
| +35% | +$575K |
|
1629
Extreme Networks
EXTR
$3.94B
| $2.2M | ﹤0.01% |
276,065
+12,164
| +5% | +$117K |
|
1630
SunCoke Energy
SXC
$720M
| $2.2M | ﹤0.01% |
163,902
+3,834
| +2% | +$47.5K |
|
1631
Heartland Express
HTLD
$948M
| $2.19M | ﹤0.01% |
118,036
+819
| +0.7% | +$15.1K |
|
|
DBD
1632
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.19M | ﹤0.01% |
183,148
+51,976
| +40% | +$696K |
|
|
PINC
1633
DELISTED
Premier
PINC
| $2.19M | ﹤0.01% |
60,145
-4,711
| -7% | -$156K |
|
1634
Ormat Technologies
ORA
$6B
| $2.18M | ﹤0.01% |
41,048
+1,307
| +3% | +$71.4K |
|
1635
Super Micro Computer
SMCI
$18.4B
| $2.18M | ﹤0.01% |
923,160
+14,930
| +2% | +$32.6K |
|
1636
Liberty Latin America Class C
LILAK
$1.63B
| $2.17M | ﹤0.01% |
+130,623
| New | +$2.28M |
|
1637
NovoCure
NVCR
$1.73B
| $2.17M | ﹤0.01% |
69,161
+14,651
| +27% | +$408K |
|
|
BNFT
1638
DELISTED
Benefitfocus, Inc.
BNFT
| $2.16M | ﹤0.01% |
64,412
+37,823
| +142% | +$1.19M |
|
|
CLVS
1639
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.16M | ﹤0.01% |
47,586
+4,110
| +9% | +$200K |
|
1640
Shutterstock
SSTK
$198M
| $2.15M | ﹤0.01% |
45,396
+2,455
| +6% | +$117K |
|
|
OSG
1641
Octave Specialty Group
OSG
$243M
| $2.15M | ﹤0.01% |
108,325
+63,529
| +142% | +$1.17M |
|
1642
Rayonier Advanced Materials
RYAM
$604M
| $2.14M | ﹤0.01% |
125,460
+7,982
| +7% | +$154K |
|
|
UHT
1643
Universal Health Realty Income Trust
UHT
$603M
| $2.14M | ﹤0.01% |
33,445
+1,582
| +5% | +$97.5K |
|
|
MAGN
1644
Magnera Corp
MAGN
$472M
| $2.13M | ﹤0.01% |
8,380
+21
| +0.3% | +$5.19K |
|
1645
Pathward Financial
CASH
$1.86B
| $2.13M | ﹤0.01% |
65,622
+1,281
| +2% | +$46.5K |
|
|
NAV
1646
DELISTED
Navistar International
NAV
| $2.13M | ﹤0.01% |
52,317
-166
| -0.3% | -$6.34K |
|
|
ARNA
1647
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.12M | ﹤0.01% |
48,581
+10,883
| +29% | +$468K |
|
1648
Alamo Group
ALG
$1.94B
| $2.11M | ﹤0.01% |
23,344
+718
| +3% | +$72.8K |
|
|
LGF.B
1649
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.1M | ﹤0.01% |
89,735
-11,855
| -12% | -$275K |
|
1650
WesBanco
WSBC
$3.97B
| $2.09M | ﹤0.01% |
46,501
+3,231
| +7% | +$146K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, RhumbLine Advisers held 3,019 positions worth $49.6B, up 3.6% from $47.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2018 filing shows 199 new, 1,870 increased, 823 reduced and 112 closed positions. Its largest new stake was Evergy: 490,078 shares worth $27.5M. The largest sale was Time Warner Inc, an estimated $130M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2018 buy was Evergy: 490,078 shares worth $27.5M.
- RhumbLine Advisers added most to AT&T in Q2 2018, an estimated $61.6M increase.
- RhumbLine Advisers's biggest Q2 2018 reduction was Apple, cutting an estimated $21.2M.
- RhumbLine Advisers fully exited Time Warner Inc in Q2 2018, selling an estimated $130M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $49.6B portfolio in Q2 2018.
- RhumbLine Advisers opened 199 new positions and closed 112 in Q2 2018.
- RhumbLine Advisers's portfolio value rose 3.6% quarter-over-quarter to $49.6B.
Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.